What antipsychotics have a low risk of inducing seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antipsychotics with Low Seizure Risk

For patients with absent seizures or epilepsy requiring antipsychotic treatment, aripiprazole, risperidone (at doses ≤6 mg/day), amisulpride, haloperidol, and fluphenazine are preferred due to their significantly lower seizure-inducing potential compared to other antipsychotics. 1, 2, 3

Highest Risk Antipsychotics to Avoid

  • Clozapine carries the highest seizure risk among all antipsychotics, with approximately 3-5% of patients experiencing seizures, increasing to 5% at high doses 4, 1, 2
  • Chlorpromazine has the greatest seizure risk among first-generation antipsychotics and should be avoided 4, 2, 3
  • Thioridazine is associated with increased seizure risk (adjusted odds ratio 1.78) 1
  • Low-to-medium potency first-generation antipsychotics (chlorpromazine, zuclopenthixol, flupenthixol, pericyazine, promazine, thioridazine) show seizure incidence rates of 49.4 per 10,000 person-years 5

Recommended Low-Risk Options

Second-Generation Antipsychotics (Preferred)

  • Aripiprazole demonstrates lower likelihood of causing extrapyramidal symptoms and appears to have minimal seizure risk 4, 2, 3
  • Risperidone confers relatively low seizure risk when used at appropriate doses (≤6 mg/24h to minimize extrapyramidal side effects) 4, 2, 3, 5
  • Amisulpride poses significantly lower seizure risk 2, 5
  • Quetiapine shows variable data: while some research suggests lower seizure risk 2, FDA labeling reports seizures in 0.5% of patients versus 0.2% on placebo 6, and one study found it reduces seizure activity during ECT 7
  • Olanzapine has intermediate risk with seizure incidence of 32.6 per 10,000 person-years 5

First-Generation Antipsychotics (Alternative)

  • Haloperidol is associated with lower seizure risk and may be used cautiously 4, 3, 5
  • Fluphenazine demonstrates lower seizure induction risk 3, 7
  • Pimozide and trifluoperazine also show lower seizure risk 3

Critical Dosing Principles

Start low and titrate slowly to minimize seizure risk, as seizures triggered by antipsychotics are dose-dependent 2, 8

  • Begin with the smallest effective dose 2, 8
  • Avoid rapid dose escalation 2, 3
  • Monitor serum drug levels when available 2
  • Maintain the minimal effective dose 2, 8

Special Populations

Patients with Dementia

In dementia patients, amisulpride, aripiprazole, risperidone, or sulpiride showed no increased seizure risk (adjusted odds ratio 0.92), while other antipsychotic classes increased risk 2-3 fold 5

Patients with Affective Disorders

Medium-to-high potency first-generation antipsychotics increased seizure risk 2.51-fold, while second-generation options did not significantly increase risk 5

Common Pitfalls to Avoid

  • Avoid polypharmacy: Complex drug combinations increase seizure risk through drug-drug interactions and additive threshold-lowering effects 3, 8
  • Monitor for metabolic factors: Slow drug metabolism and metabolic disturbances increase seizure likelihood 3
  • Screen for seizurogenic conditions: History of epilepsy, brain damage, concurrent medications that lower seizure threshold, and Alzheimer's dementia all increase risk 6, 3, 8
  • Avoid combining with other threshold-lowering drugs: Quetiapine specifically should not be combined with medications known to prolong QTc or lower seizure threshold 6

Monitoring Requirements

  • Baseline assessment for seizure history and risk factors 6, 8
  • Use cautiously in patients ≥65 years, as conditions lowering seizure threshold are more prevalent 6
  • Consider EEG monitoring if using higher-risk agents 2
  • Maintain complete blood count monitoring if using quetiapine due to neutropenia risk, which can complicate clinical picture 6

References

Guideline

Antipsychotics and Seizure Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antipsychotic drugs in epilepsy.

Neurologia i neurochirurgia polska, 2019

Research

Antipsychotic medication and seizures: a review.

Drugs of today (Barcelona, Spain : 1998), 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.